292 related articles for article (PubMed ID: 32923703)
1. Current status and future prospects of protein vaccine candidates against
Eyayu T; Zeleke AJ; Worku L
Parasite Epidemiol Control; 2020 Nov; 11():e00176. PubMed ID: 32923703
[TBL] [Abstract][Full Text] [Related]
2. Cross-species protection: Schistosoma mansoni Sm-p80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons.
Karmakar S; Zhang W; Ahmad G; Torben W; Alam MU; Le L; Damian RT; Wolf RF; White GL; Carey DW; Carter D; Reed SG; Siddiqui AA
Vaccine; 2014 Mar; 32(11):1296-303. PubMed ID: 24397898
[TBL] [Abstract][Full Text] [Related]
3.
Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
Front Immunol; 2018; 9():1762. PubMed ID: 30105029
[TBL] [Abstract][Full Text] [Related]
4.
Zhang W; Ahmad G; Molehin AJ; Torben W; Le L; Kim E; Lazarus S; Siddiqui AJ; Carter D; Siddiqui AA
J Investig Med; 2018 Dec; 66(8):1124-1132. PubMed ID: 29997146
[TBL] [Abstract][Full Text] [Related]
5. A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against
Alves CC; Araujo N; Bernardes WPOS; Mendes MM; Oliveira SC; Fonseca CT
Front Immunol; 2018; 9():2488. PubMed ID: 30450095
[TBL] [Abstract][Full Text] [Related]
6. A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.
Keitel WA; Potter GE; Diemert D; Bethony J; El Sahly HM; Kennedy JK; Patel SM; Plieskatt JL; Jones W; Deye G; Bottazzi ME; Hotez PJ; Atmar RL
Vaccine; 2019 Oct; 37(43):6500-6509. PubMed ID: 31515141
[TBL] [Abstract][Full Text] [Related]
7. Combination of the two schistosomal antigens Sm14 and Sm29 elicits significant protection against experimental Schistosoma mansoni infection.
Ewaisha RE; Bahey-El-Din M; Mossallam SF; Amer EI; Aboushleib HM; Khalil AM
Exp Parasitol; 2014 Oct; 145():51-60. PubMed ID: 25092439
[TBL] [Abstract][Full Text] [Related]
8. A vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasis.
Ricciardi A; Visitsunthorn K; Dalton JP; Ndao M
BMC Infect Dis; 2016 Mar; 16():112. PubMed ID: 26945988
[TBL] [Abstract][Full Text] [Related]
9. A multivalent chimeric vaccine composed of Schistosoma mansoni SmTSP-2 and Sm29 was able to induce protection against infection in mice.
Pinheiro CS; Ribeiro AP; Cardoso FC; Martins VP; Figueiredo BC; Assis NR; Morais SB; Caliari MV; Loukas A; Oliveira SC
Parasite Immunol; 2014 Jul; 36(7):303-12. PubMed ID: 24749785
[TBL] [Abstract][Full Text] [Related]
10. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
[TBL] [Abstract][Full Text] [Related]
11. The use of a conformational cathepsin D-derived epitope for vaccine development against Schistosoma mansoni.
Ahmad Fuaad AA; Roubille R; Pearson MS; Pickering DA; Loukas AC; Skwarczynski M; Toth I
Bioorg Med Chem; 2015 Mar; 23(6):1307-12. PubMed ID: 25684420
[TBL] [Abstract][Full Text] [Related]
12. Human T cell epitope mapping of the Schistosoma mansoni 14-kDa fatty acid-binding protein using cells from patients living in areas endemic for schistosomiasis.
Fonseca CT; Cunha-Neto E; Goldberg AC; Kalil J; de Jesus AR; Carvalho EM; Correa-Oliveira R; Oliveira SC
Microbes Infect; 2005 Feb; 7(2):204-12. PubMed ID: 15725385
[TBL] [Abstract][Full Text] [Related]
13. Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection model.
Mossallam SF; Amer EI; Ewaisha RE; Khalil AM; Aboushleib HM; Bahey-El-Din M
BMC Infect Dis; 2015 Mar; 15():147. PubMed ID: 25887456
[TBL] [Abstract][Full Text] [Related]
14. Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults.
Santini-Oliveira M; Coler RN; Parra J; Veloso V; Jayashankar L; Pinto PM; Ciol MA; Bergquist R; Reed SG; Tendler M
Vaccine; 2016 Jan; 34(4):586-594. PubMed ID: 26571311
[TBL] [Abstract][Full Text] [Related]
15. Kunitz-type protease inhibitor as a vaccine candidate against schistosomiasis mansoni.
Ranasinghe SL; Duke M; Harvie M; McManus DP
Int J Infect Dis; 2018 Jan; 66():26-32. PubMed ID: 29128645
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the immune response and protective efficacy of Schistosoma mansoni Cathepsin B in mice using CpG dinucleotides as adjuvant.
Ricciardi A; Dalton JP; Ndao M
Vaccine; 2015 Jan; 33(2):346-53. PubMed ID: 25448114
[TBL] [Abstract][Full Text] [Related]
17. Lipid core peptide targeting the cathepsin D hemoglobinase of Schistosoma mansoni as a component of a schistosomiasis vaccine.
Dougall AM; Skwarczynski M; Khoshnejad M; Chandrudu S; Daly NL; Toth I; Loukas A
Hum Vaccin Immunother; 2014; 10(2):399-409. PubMed ID: 24231271
[TBL] [Abstract][Full Text] [Related]
18. Sm-p80-based vaccine trial in baboons: efficacy when mimicking natural conditions of chronic disease, praziquantel therapy, immunization, and Schistosoma mansoni re-encounter.
Siddiqui AJ; Molehin AJ; Zhang W; Ganapathy PK; Kim E; Rojo JU; Redman WK; Sennoune SR; Sudduth J; Freeborn J; Hunter D; Kottapalli KR; Kottapalli P; Wettashinghe R; van Dam GJ; Corstjens PLAM; Papin JF; Carey D; Torben W; Ahmad G; Siddiqui AA
Ann N Y Acad Sci; 2018 Aug; 1425(1):19-37. PubMed ID: 29888790
[TBL] [Abstract][Full Text] [Related]
19. Solution structure, membrane interactions, and protein binding partners of the tetraspanin Sm-TSP-2, a vaccine antigen from the human blood fluke Schistosoma mansoni.
Jia X; Schulte L; Loukas A; Pickering D; Pearson M; Mobli M; Jones A; Rosengren KJ; Daly NL; Gobert GN; Jones MK; Craik DJ; Mulvenna J
J Biol Chem; 2014 Mar; 289(10):7151-7163. PubMed ID: 24429291
[TBL] [Abstract][Full Text] [Related]
20. Prospects for a schistosome vaccine.
Capron A; Riveau GJ; Bartley PB; McManus DP
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Oct; 2(3):281-90. PubMed ID: 12476492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
